Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 12
2014 3
2015 4
2016 8
2017 4
2018 11
2019 20
2020 14
2021 17
2022 20
2023 17
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 36517061

101 results

Results by year

Filters applied: . Clear all
Page 1
[Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP, Wang LF, Liu Y, Li KB, Xu L, Li WM, Ni ZH, Xia K, Zhang ZY, Yang XC. Zhang DP, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):600-607. doi: 10.3760/cma.j.cn112148-20200327-00254. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32842271 Chinese.
Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial.
Wöhrle J, Scheller B, Seeger J, Farah A, Ohlow MA, Mangner N, Möbius-Winkler S, Weilenmann D, Stachel G, Leibundgut G, Rickenbacher P, Cattaneo M, Gilgen N, Kaiser C, Jeger RV; BASKET-SMALL 2 Investigators. Wöhrle J, et al. JACC Cardiovasc Interv. 2021 Aug 23;14(16):1789-1798. doi: 10.1016/j.jcin.2021.06.025. JACC Cardiovasc Interv. 2021. PMID: 34412797 Free article. Clinical Trial.
Impact of diabetes on long-term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry.
Bruno F, Kang J, Elia E, Han JK, De Filippo O, Yang HM, Gallone G, Park KW, De Luca L, Kang HJ, Quadri G, Gwon HC, Chun WJ, Giannino G, Hur SH, Han SH, Truffa A, Bin Song Y, Cortese B, Choi KH, Chieffo A, Hong SJ, Di Pietro G, Doh JH, Wanha W, Nam CW, Kim HS, Mattesini A, de De Ferrari GM, Koo BK, D'Ascenzo F. Bruno F, et al. Catheter Cardiovasc Interv. 2023 Oct;102(4):620-630. doi: 10.1002/ccd.30802. Epub 2023 Sep 5. Catheter Cardiovasc Interv. 2023. PMID: 37668085
Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: One-year outcomes and optical coherence tomography assessment.
Mitsui K, Lee T, Miyazaki R, Hara N, Nagamine S, Nakamura T, Terui M, Okata S, Nagase M, Nitta G, Watanabe K, Kaneko M, Nagata Y, Nozato T, Ashikaga T. Mitsui K, et al. Catheter Cardiovasc Interv. 2023 Jul;102(1):11-17. doi: 10.1002/ccd.30689. Epub 2023 May 20. Catheter Cardiovasc Interv. 2023. PMID: 37210618
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A. Naganuma T, et al. JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005. JACC Cardiovasc Interv. 2013. PMID: 24355114 Free article.
101 results